Virica Biotech

Virica Optimizes the Production of Viral Drugs, Enabling Developers to Deploy Their Products at Scale. Virica's Viral Sensitization Enhancer (VSE™) Platform Reduces Production Inefficiencies Caused by Innate Antiviral Defenses in Production Cells. Customizable viral sensitizers significantly increase production yields and reduce costs across a range of products, including vaccines, cell and gene therapies, and anticancer treatments. Our viral sensitizer technology includes a database of over 100 small molecules that can safely overcome natural immune defenses in humans and animals that inhibit effective viral drug performance. When immune responses are safely reduced, targeted infections by therapeutic viruses can be improved. This has many practical and sought-after applications, positively contributing to public health goals and better clinical care.